{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:05:04Z","timestamp":1775570704480,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"DOI":"10.7759\/cureus.103117","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:38:25Z","timestamp":1770413905000},"source":"Crossref","is-referenced-by-count":1,"title":["Flaccid Lower Limb Paraparesis Despite Infiltration of the Spinal Cord by a Secondary Central Nervous System T-cell Non-Hodgkin Lymphoma With Syringomyelia: A Case Report"],"prefix":"10.7759","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Non-Hodgkin lymphoma","author":"Sapkota S","year":"2025","unstructured":"Sapkota S, Shaikh H. Non-Hodgkin lymphoma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref2","article-title":"National Guideline Alliance (UK). Non-Hodgkin's Lymphoma: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.) 2, Diagnosis. Available from","author":"National Guideline Alliance (UK)","year":"2016","unstructured":"National Guideline Alliance (UK). Non-Hodgkin's Lymphoma: Diagnosis and Management. National Institute for Health and Care Excellence (NICE), London; 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385274\/."},{"key":"ref3","article-title":"Non-hodgkin lymphoma treatment (PDQ\u00ae)","year":"2023","unstructured":"Non-hodgkin lymphoma treatment (PDQ\u00ae). PDQ Cancer Information Summaries [Internet]. 2002 (ed). National Cancer Institute (US), Bethesda (MD); 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900080305","article-title":"Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors","volume":"8","author":"Liang R","year":"1990","unstructured":"Liang R, Chiu E, Loke SL. Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors. Hematol Oncol. 1990, 8:141-5. 10.1002\/hon.2900080305","journal-title":"Hematol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.606","article-title":"A systematic approach to the diagnosis of suspected central nervous system lymphoma","volume":"70","author":"Scott BJ","year":"2013","unstructured":"Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013, 70:311-9. 10.1001\/jamaneurol.2013.606","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104844","article-title":"Types of T-cell lymphoma-a cytogenetic perspective","volume":"84","author":"Samad MA","year":"2022","unstructured":"Samad MA, Mahboob E, Shafiq A, Ur Rehman MH, Sheikh A, Tharwani ZH. Types of T-cell lymphoma-a cytogenetic perspective. Ann Med Surg (Lond). 2022, 84:104844. 10.1016\/j.amsu.2022.104844","journal-title":"Ann Med Surg (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medsci9010005","article-title":"Epidemiology of non-Hodgkin's lymphoma","volume":"9","author":"Thandra KC","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P. Epidemiology of non-Hodgkin's lymphoma. Med Sci (Basel). 2021, 9:5. 10.3390\/medsci9010005","journal-title":"Med Sci (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.19230\/jonnpr.4820","article-title":"Meningeal carcinomatosis as the initial manifestation of lymphoma","volume":"7","author":"Aragon\u00e9s LG","year":"2022","unstructured":"Aragon\u00e9s LG, Montoya Morcillo MC, Donoso Esteban I, Broseta Viana L, Garc\u00eda del Poz JS. Meningeal carcinomatosis as the initial manifestation of lymphoma. J Negative Res. 2022, 7:322-7. 10.19230\/jonnpr.4820","journal-title":"J Negative Res"},{"key":"ref9","article-title":"Guillain-Barre syndrome","author":"Nguyen TP","year":"2023","unstructured":"Nguyen TP, Taylor RS. Guillain-Barre syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.22037\/ijcn.v15i4.31285","article-title":"Cytomegalovirus infection and Guillain-Barr\u00e9 syndrome: the first case-control study in Iran","volume":"15","author":"Mamishi S","year":"2021","unstructured":"Mamishi S, Ashrafi MR, Mohammadi M, Zamani G, Pourakbari B, Mahmoudi S, Aziz-Ahari S. Cytomegalovirus infection and Guillain-Barr\u00e9 syndrome: the first case-control study in Iran. Iran J Child Neurol. 2021, 15:35-41. 10.22037\/ijcn.v15i4.31285","journal-title":"Iran J Child Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102248","article-title":"Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma","volume":"9","author":"Geurts YM","year":"2024","unstructured":"Geurts YM, Neppelenbroek SI, Aleman BM, et al.. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma. ESMO Open. 2024, 9:102248. 10.1016\/j.esmoop.2024.102248","journal-title":"ESMO Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08484-5","article-title":"Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes","volume":"32","author":"Li T","year":"2024","unstructured":"Li T, Trinh T, Bosco A, Kiernan MC, Goldstein D, Park SB. Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes. Support Care Cancer. 2024, 32:278. 10.1007\/s00520-024-08484-5","journal-title":"Support Care Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175662","article-title":"Vincristine-induced neuropathy in patients diagnosed with solid and hematological malignancies: the role of dose rounding","volume":"12","author":"Alwhaibi AM","year":"2023","unstructured":"Alwhaibi AM, Alshamrani AA, Alenazi MA, et al.. Vincristine-induced neuropathy in patients diagnosed with solid and hematological malignancies: the role of dose rounding. J Clin Med. 2023, 12:5662. 10.3390\/jcm12175662","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46063","article-title":"Vincristine-induced peripheral neuropathy in children with malignancy and the effect of missed doses on treatment success","volume":"15","author":"Eker N","year":"2023","unstructured":"Eker N, Ozturk G. Vincristine-induced peripheral neuropathy in children with malignancy and the effect of missed doses on treatment success. Cureus. 2023, 15:46063. 10.7759\/cureus.46063","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-12093","article-title":"Neuropathy after cyclophosphamide high-dose chemotherapy in a Morbus Werlhof patient","volume":"126","author":"Tsch\u00f6p K","year":"2001","unstructured":"Tsch\u00f6p K, Rommel F, Schmidkonz P, Emmerich B, Schulze J. Neuropathy after cyclophosphamide high-dose chemotherapy in a Morbus Werlhof patient. Dtsch Med Wochenschr. 2001, 126:17-20. 10.1055\/s-2001-12093","journal-title":"Dtsch Med Wochenschr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.1.95","article-title":"Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia","volume":"4","author":"Powell BL","year":"1986","unstructured":"Powell BL, Capizzi RL, Lyerly ES, Cooper MR. Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia. J Clin Oncol. 1986, 4:95-7. 10.1200\/JCO.1986.4.1.95","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24951","article-title":"Chemotherapy-induced peripheral neuropathy: a current review","volume":"81","author":"Staff NP","year":"2017","unstructured":"Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017, 81:772-81. 10.1002\/ana.24951","journal-title":"Ann Neurol"},{"key":"ref18","article-title":"Corticosteroid induced myopathy","author":"Surmachevska N","year":"2023","unstructured":"Surmachevska N, Tiwari V. Corticosteroid induced myopathy. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/a-2246-2900","article-title":"Glucocorticoid-induced myopathy: typology, pathogenesis, diagnosis, and treatment","volume":"56","author":"Wu M","year":"2024","unstructured":"Wu M, Liu C, Sun D. Glucocorticoid-induced myopathy: typology, pathogenesis, diagnosis, and treatment. Horm Metab Res. 2024, 56:341-9. 10.1055\/a-2246-2900","journal-title":"Horm Metab Res"},{"key":"ref20","article-title":"Electrodiagnostic evaluation of myopathy","author":"Shanina E","year":"2022","unstructured":"Shanina E, Smith RG. Electrodiagnostic evaluation of myopathy. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459403-flaccid-lower-limb-paraparesis-despite-infiltration-of-the-spinal-cord-by-a-secondary-central-nervous-system-t-cell-non-hodgkin-lymphoma-with-syringomyelia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T21:38:26Z","timestamp":1770413906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459403-flaccid-lower-limb-paraparesis-despite-infiltration-of-the-spinal-cord-by-a-secondary-central-nervous-system-t-cell-non-hodgkin-lymphoma-with-syringomyelia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.103117","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}